Suporte à decisão
Digital platform that combines thermography and artificial intelligence for quick and accurate assessments, focusing on injury prevention in athletes. It also offers computer vision and AI solutions for optimizing medical processes.
Site
Offers AI-powered software to assist radiologists in generating structured medical reports quickly and accurately. The platform integrates voice recognition, streamlining data input and processing, and ensuring that reports follow recommended clinical standards.
Site
Brazil’s largest health and benefits marketplace, combining technology and purpose to transform corporate benefits into personalized health experiences. With over 2,000 products and centralized management in one place, we deliver efficiency for companies and flexibility of choice for those who matter most: people.
Site
Focused on specialized miRNA molecules that target multiple factors in cancer development while minimizing immune reactions and off-target effects. This approach can treat various cancers, and it is delivered to tumors using a novel biocompatible drug delivery system that forms nanoparticles with nucleic acids.
Site
Focused on creating advanced treatments with modified microRNAs that target and repair damaged tissue in osteoarthritis patients. This approach not only alleviates pain but also promotes long-term cartilage regeneration, offering a non-surgical solution for millions affected by this condition.
Site
AI-based system that, through biosensors and analysis of intestinal microbiota, accurately predicts the glycemic response of each dietary intake on a personalized basis. This solution empowers users to proactively manage glycemic fluctuations, thereby mitigating the risk of metabolic disorders such as diabetes and obesity
Site
Proprietary drug discovery platform uses advanced artificial intelligence algorithms to map promising species in biodiversity with the goal of developing therapies and medications. To achieve this, it decodes the chemical structures of the species, identifies active compounds, and predicts the bioactivity of these molecules, focusing on neurological diseases.
Site
Artificial intelligence solutions to assist in cancer diagnosis, focusing on digital pathology. The first version identifies suspicious areas of lung cancer in histological slides, classifying them as adenocarcinoma or squamous cell carcinoma. In the future, the technology will also detect small cell cancer and other types, such as prostate cancer.
Terapias
Biotech focada em terapia celular para câncer. Está em fase clínica para melanoma e avançando para tumores sólidos.
Site
Immunotherapy aimed at treating cancer and infectious diseases. The Act-Tera platform reprograms the immune system, enabling it to recognize and eliminate infected or cancerous cells through the activation of T cells. One of the focuses is on diseases associated with HPV-16, utilizing TERAH-7.
Site
Leverages cell therapy in the development of health products, including the 3D stem cell dressing for chronic wounds and severe burns, the extracellular vesicle nano-ointment for less complex wounds and scars, and the 3D bio-graft for gum recession for health promotion and healing.
Site
Biopharmaceutical asparaginase, used for the treatment of acute lymphoblastic leukemia, focusing on metabolic engineering techniques to produce vegan, cruelty-free hyaluronic acid derived from yeast.
Site
Offers a free app for community health agents (ACS), which facilitates registration and home visits. The data collected can be formatted and sent to the Ministry of Health and used by municipalities for the formulation of public policies. The startup also creates solutions for decentralized clinical trials.
Site
Platform that automates the perioperative journey, providing support to anesthesiologists at the point of care. With integrated artificial intelligence, it generates data that helps in business management, as well as predicting and preventing complications in anesthetic procedures.
Site
Digital solution that promotes prevention and access to ophthalmology through technology, offering everything from ophthalmological screening via chatbot and AI vision tests to online consultations and comprehensive care with special conditions.
Site
Dermocosmetic products based on natural compounds for the skin and oral mucosa care of oncology patients experiencing dryness, wounds, and burns from chemotherapy and radiotherapy. The aim is to improve quality of life and ensure that treatment is not interrupted due to these burns and wounds.
Site
Digital solution for planning and sizing work schedules under CLT, ensuring agility, operational efficiency, and reports to facilitate decision-making.
Site
The largest independent telemedicine platform in Latin America, providing comprehensive digital health solutions.
Site
Device that monitors stock, consumption, automatic recording, and checking of medical oxygen, increasing safety, treatment quality, and the productivity of the care team. Also created HAI, software for real-time planning and management of Care Plans and Home Care Protocols.
Site
Leverages data analysis and science to monitor and predict blood bank inventory and consumption, preventing shortages and waste of blood units.
Site
Monitors and remotely guides oncology patients throughout diagnosis, consultations, exams, and treatment. Using an app, the healthcare team tracks symptoms and provides personalized care according to the patients' needs.
Site
Through a brain-machine interface, stimulate neuroplasticity with the aid of a brain-controlled exoskeleton to create new neural connections capable of restoring lost upper limb movement.
Site
The Eyer is a high-quality portable retinograph for ophthalmic exams that uses Artificial Intelligence to analyze captured images and provide real-time results
Site
Specializing in pharmacogenetics, the company develops products that use genetic testing to identify how each individual responds to specific medications, enabling more effective treatments, with its main focus being the line dedicated to mental health.
Site
Offers personalized, lightweight, adjustable, and hypoallergenic orthoses for orthopedic immobilization, produced using 3D printers. The startup has also developed intuitive software and an app to precisely scan the immobilization area.
Site
Software for printing personalized 3D orthoses, using plastic, thermomoldable, and biodegradable materials, covering everything from joint immobilizations to surgical planning.
Site
Focused on solutions to stimulate brain connections in an engaging and challenging way, the company aims to enhance focus, memory, attention, and communication skills with over 120 games on its technological platform.
Site
Detection and monitoring of obstructive sleep apnea directly in the patient's home, using a high-resolution oximeter, actigraph, and the app.
Site
Offers an AI-powered automation and communication solution for surgical centers. Its modular, plug-and-play system optimizes patient flow, streamlines check-in, and enhances team communication, reducing delays and improving operational efficiency.
Site
Applies genetics-based technology for microbiome analysis, assisting in everything from the diagnosis of complex diseases to the development of new biomarkers and therapeutic targets. Among its products are tests for the evaluation of the gut, vaginal, oral, and skin microbiomes.
Site
It offers patients the convenience of undergoing tests and receiving vaccinations at home at a reduced cost.
Site
Uses audio and artificial intelligence to automatically generate all necessary clinical documentation, such as anamnesis, medical certificates, surgical descriptions, exam requests, and more, allowing physicians to fully focus on patient care.
Site
SaaS platform for patient care management, facilitating acquisition, engagement, and navigation. The solution centralizes data for teams and automates tasks, increasing efficiency and service capacity.
Site
Medical education platform designed for early-career professionals, particularly those preparing for residency exams. It incorporates Artificial Intelligence to guide studies more effectively.
Site
Uses artificial intelligence to forecast demand and manage blood inventories, helping blood banks prevent shortages and waste, while also engaging donors in a personalized way.
Site
Is developing a tool that transforms voice recordings into digital vocal biomarkers, enabling the tracking and monitoring of patients with Alzheimer’s, Parkinson’s, and other neurodegenerative diseases.
Site
Address the unmet need for effective neurodegenerative diseases treatments by developing solutions based on neural stem cells-derived exosomes. These exosomes promote neuronal regeneration and provide neuroprotection. What sets Exomas' solution apart is its ability to stimulate the body's natural repair mechanisms
Ver site
Address the unmet need for effective neurodegenerative diseases treatments by developing solutions based on neural stem cells-derived exosomes.
These exosomes promote neuronal regeneration and provide neuroprotection. What sets Exomas' solution apart is its ability to stimulate the body's natural repair mechanisms
Site
GAMEET transforms fertility treatments using 3D-printed devices designed to improve embryo quality by minimizing manipulation and emulating natural biological processes that occur within the female reproductive system.
Site
BioSima is a platform dedicated to the development of biopharmaceuticals based on exosome concentrates, with a focus on the fields of Endocrinology, Orthopedics, and Neurology. Among its pipeline products, Neurexo stands out: an intranasal spray composed of exosomes enriched with miRNA, designed for the treatment of Alzheimer's disease.
Site
GlycoX is a Brazilian biotechnology startup developing an oral formulation derived from a bioactive compound found in Brazilian biodiversity, designed to control diabetic cardiomyopathy and hyperglycemia.
Site
Debora Heller e Manuel Jimenez, after participating in the Eretz.bio (DeepUp) Deeptech Startup Creation Program, founded Saliva PRO, a Brazilian biotechnology startup that is developing a saliva-based diagnostic and artificial intelligence solution to assess performance and prevent injuries. The company is building a technology that enables real-time monitoring of biomarkers and, by integrating this data, provides insights that guide training personalization and individualized recovery strategies.
Site
CellRep is developing cell reprogramming supported by AI to optimize CAR-T therapies, increasing their effectiveness against solid tumors while aiming to reduce manufacturing time and costs, without genetic editing. The approach under development seeks to generate more potent and durable T cells, designed to target and eliminate solid tumors more effectively.
Site
Exits de Startups
